Cattle & Porcine/Swine Reproductive Diseases Market worth $975.8 million by 2029

As per the recently published report by MarketsandMarket?, The report "Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029", is projected to reach USD 975.8 million by 2029 from USD 758.2 million in 2024 at a CAGR of 5.2%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241160711 ?

Browse

• 335? ??Market Data Tables
• 66? ? ??Figures
• 333? ??Pages and in-depth TOC on?"Cattle & Porcine/Swine Reproductive Diseases Market - Global Forecast to 2029”

Some of the prominent key players are:

• Zoetis Inc. (US),
• Merck & Co., Inc. (US),
• Boehringer Ingelheim International GmBH (Germany),
• Virbac (France),
• Elanco Animal Health Incorporated (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Cattle & Porcine/Swine Reproductive Diseases Market.

• In 2023, the pharma market segment dominated the global Cattle & porcine/swine reproductive diseases market. Such high growth rates could be attributed to advancements in vaccine manufacturing, such as more effective formulations and sustainable production practices that have driven growth within this segment, besides increasing incidences of reproductive diseases within farm animals that create a high demand for these pharmaceutical products.
• This segment of Porcine Reproductive and Respiratory Syndrome accounts for the second largest share in the Cattle & porcine/swine reproductive diseases market. It is fueled by its high incidence and the high economic cost it incurs within the pig industry. PRRS causes severe reproductive failures in breeding animals and respiratory complications in young pigs, which lead to severe losses in production.
• Porcine segment had the highest CAGR in the Cattle & porcine/swine reproductive diseases market. Growth of Porcine segment in this Market is driven by multiple factors. Primarily, the global rise in pork consumption and the intensification of pig farming practices elevate the risk of disease transmission, which, in turn, emphasizes the need for effective disease control measures.
• Among the end-user type, cattle and porcine farms led in accounting for the largest market share in the cattle & porcine/swine reproductive diseases market in 2023. Growth progresses through various factors. First, with an increase in farming operations and increasing herd sizes, the susceptibility of such outbreaks increases manifold, which further results in the need for more strenuous management solutions for the diseases.
• The rapid growth in the APAC region in terms of urbanization and increase in population has put massive pressure on meat demand, contributing to increased livestock farming. This increased pressure has increased awareness and investment in animal health, particularly reproductive disease management.?

Request Free Sample Report:?https://www.marketsandmarkets.com/requestsampleNew.asp?id=241160711

A few factors are contributing to the growth of the cattle & porcine/swine reproductive diseases market. Rising demand for meat and dairy products in the consumer market is making more focus on keeping animals healthy, thus increasing the demand for solution products related to their reproductive health. Growing problems related to reproductive health in cattle and pigs increase the demand for treatments and preventative measures. An increase in veterinary practitioners across the developed areas is also improving access to care, which is further supporting market expansion. In addition, better government and animal welfare activities are promoting more healthy animal practices, which subsequently increases veterinary product adoption. All these factors are therefore contributing to increased growth in the market as there will be a greater need for efficient reproductive health management in livestock.

?